Beta Drugs Limited - Penyata Pendapatan (TTM)

Beta Drugs Limited
IN ˙ NSEI
Penyata Pendapatan (TTM)

Beta Drugs Limited Penyata Pendapatan menunjukkan perubahan dalam pendapatan dan perbelanjaan sepanjang tempoh masa tertentu. Data Penyata Pendapatan termasuk Jualan dan Hasil, Untung Kasar, Penyelidikan dan Pembangunan (R&D), Jualan, Perbelanjaan Am dan Pentadbiran (SG&A), Pendapatan Operasi, Perbelanjaan Cukai Pendapatan, Perbelanjaan Faedah, Pendapatan Bukan Operasi, Perolehan sesaham (EPS), dan Saham Diterbitkan.

Semua nombor adalah kali 1,000,000 kecuali setiap unit saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
Hasil 956 1,058 1,161 1,345 1,528 1,683 1,838 1,960 2,081 2,176 2,271 2,416 2,560 2,759 2,957 3,152 3,347 3,486 3,624
Perubahan (%) 10.75 9.71 15.81 13.65 10.14 9.21 6.61 6.20 4.56 4.36 6.36 5.98 7.76 7.20 6.60 6.19 4.12 3.96
% daripada Hasil 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Kos jualan 583 654 723 838 953 1,038 1,123 1,173 1,223 1,260 1,297 1,396 1,491 1,648 1,814 1,913 2,012 2,066 2,120
Perubahan (%) 12.13 10.58 15.92 13.73 8.95 8.22 4.42 4.23 3.08 2.87 7.67 6.78 10.57 10.03 5.46 5.18 2.68 2.61
% daripada Hasil 61.00 61.75 62.24 62.30 62.35 61.67 61.11 59.86 58.75 57.92 57.09 57.80 58.24 59.76 61.34 60.68 60.10 59.27 58.50
Keuntungan Operasi Kasar 373 405 438 507 575 645 715 787 859 916 974 1,019 1,069 1,110 1,143 1,239 1,336 1,420 1,504
Perubahan (%) 8.61 8.30 15.63 13.51 12.11 10.80 10.05 9.13 6.66 6.41 4.61 4.88 3.84 3.00 8.40 7.75 6.30 5.93
% daripada Hasil 39.00 38.25 37.76 37.70 37.65 38.33 38.89 40.14 41.25 42.08 42.91 42.20 41.76 40.24 38.66 39.32 39.90 40.73 41.50
SG&A 103 119 121 132 143 156 170 190 210 226 243 249 254 266 277 298 319 329 340
Perubahan (%) 16.55 1.53 8.75 8.05 9.62 8.77 11.76 10.52 7.82 7.25 2.41 2.35 4.36 4.18 7.57 7.03 3.32 3.22
% daripada Hasil 10.73 11.29 10.45 9.81 9.33 9.28 9.25 9.69 10.09 10.40 10.69 10.29 9.94 9.63 9.36 9.44 9.52 9.44 9.38
R&D
Perubahan (%)
% daripada Hasil
OpEx 818 899 982 1,119 1,257 1,370 1,484 1,579 1,675 1,758 1,841 1,958 2,075 2,266 2,456 2,623 2,789 2,896 3,003
Perubahan (%) 9.93 9.19 13.98 12.27 9.04 8.29 6.42 6.03 4.97 4.73 6.37 5.98 9.17 8.40 6.79 6.36 3.82 3.68
% daripada Hasil 85.61 84.97 84.57 83.24 82.22 81.40 80.72 80.58 80.45 80.77 81.06 81.06 81.07 82.13 83.05 83.20 83.33 83.09 82.86
Pendapatan operasi 138 159 179 225 272 313 354 381 407 419 430 457 485 493 501 530 558 590 621
Perubahan (%) 15.65 12.64 25.84 20.53 15.23 13.21 7.39 6.88 2.88 2.80 6.32 5.95 1.71 1.69 5.67 5.36 5.63 5.33
% daripada Hasil 14.39 15.03 15.43 16.76 17.78 18.60 19.28 19.42 19.55 19.23 18.94 18.94 18.93 17.87 16.95 16.80 16.67 16.91 17.14
Perbelanjaan Faedah -27 -23 -22 -21 -19 -19 -18 -19 -20 -21 -23 -24 -25 -26 -27 -29 -31 -51 -70
Perubahan (%) -14.63 -4.54 -6.15 -6.55 -4.07 -4.25 5.87 5.55 7.03 6.57 5.04 4.80 3.34 3.23 8.53 7.86 61.51 38.08
% daripada Hasil -2.85 -2.20 -1.91 -1.55 -1.27 -1.11 -0.97 -0.97 -0.96 -0.98 -1.00 -0.99 -0.98 -0.94 -0.91 -0.92 -0.94 -1.45 -1.93
Pendapatan bersih 95 106 117 150 183 216 248 269 289 298 307 327 348 356 364 387 410 417 424
Perubahan (%) 11.87 10.61 28.02 21.89 17.86 15.15 8.22 7.60 3.13 3.03 6.57 6.17 2.42 2.36 6.26 5.89 1.73 1.70
% daripada Hasil 9.92 10.01 10.10 11.16 11.97 12.81 13.51 13.71 13.89 13.70 13.53 13.55 13.58 12.90 12.32 12.28 12.25 11.97 11.71

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista